In July 2008, Affinity BioReagents, Inc. (ABR) was acquired by Thermo Fisher Scientific, Inc. ABR-Affinity BioReagents, Inc. had manufactured and distributed monoclonal and polyclonal antibodies, and recombinant proteins for the scientific research community. The company continues to offer cell biology products that include apoptosis, cell adhesion and junctions, structure markers, and cytokines; cell signaling products, such as bioactive peptides, G protein-coupled receptors, kinases, membrane receptors, steroid receptors, and steroids hormones; controls, secondaries, and tags that include blocking peptides and secondary antibodies; and muscle biology, nuclear biology, neurobiology, and stem cell biology products. Also provided are reagents and immunology services.
